MERZ PHARMA

Company Overview

Merz Pharma, founded in 1908 and headquartered in Frankfurt am Main, Germany, is a privately held pharmaceutical company specializing in aesthetic medicine and neurologically induced movement disorders. With a global presence, Merz operates through affiliates across Europe, North America, South America, and Asia-Pacific. The company’s aesthetic portfolio includes botulinum neurotoxin, a line of dermal fillers, cosmeceuticals, skin tightening and lifting devices, and regional products for dermatology, hair loss, neurology, and liver disorders.

Merz’s global operations concentrate on three key areas: medical aesthetics, neurotoxin therapies, and prescription medicines. Additionally, the company offers a range of consumer health and beauty products, emphasizing innovative solutions to meet diverse healthcare and wellness needs worldwide.

Company's Business Segments

• Pharmaceutical Products and Services : The company provides a wide range of products across three main areas: Aesthetics, Therapeutics, and Consumer Care. This includes innovative drugs, medical products for aesthetic medicine and neurological conditions, over-the-counter medications, dietary supplements, and skincare products.